Emergent BioSolutions Inc. (EBS) Balance sheet

Market cap

$446.71M

P/E ratio

	2011/12	2012/12	2013/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	144	142	179	313	272	178	112	168	622	576	643	112	106
Marketable securities, current	2	-	-	-	-	-	-	-	-	-	-	-	-
Total cash & short-term investments	146	142	179	313	272	178	112	168	622	576	643	112	106
Accounts receivable, net	74	96	61	121	138	144	263	271	231	275	158	191	155
Inventories	15	15	15	77	74	143	206	223	307	351	352	329	312
Total current assets	254	263	273	539	510	485	621	686	1,196	1,272	1,211	680	599
Property, plant and equipment, net	209	242	264	332	376	407	510	542	644	800	818	383	271
Total non-current assets	292	301	354	505	460	585	1,609	1,641	1,687	1,687	1,956	1,144	791
Total assets	547	564	627	1,044	970	1,070	2,229	2,327	2,883	2,959	3,167	1,823	1,390
Accounts payable	41	31	28	46	35	42	81	95	136	129	104	112	61
Long-term debt, current	-	4	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities	71	62	57	100	106	100	200	216	385	374	1,230	651	162
Long-term debt, non-current	54	58	62	253	248	13	785	798	841	809	449	447	664
Total non-current liabilities	59	60	81	284	268	58	1,018	1,023	1,052	966	554	523	745
Total liabilities	130	122	137	384	374	158	1,219	1,239	1,436	1,340	1,784	1,174	907
Common stock and paid-in capital	221	231	248	318	352	618	689	716	785	830	874	905	928
Retained earnings	197	220	252	351	254	337	367	422	727	958	734	-22	-212
Stockholders' equity	417	442	490	660	596	912	1,011	1,089	1,447	1,619	1,383	649	483
Total debt	59	63	62	247	248	14	795	798	841	809	449	447	664
Net debt	-86	-79	-117	-66	-23	-165	682	630	220	233	-194	335	558
D/E ratio (%)	14.3	14.2	12.7	37.4	41.6	1.5	78.6	73.3	58.1	50	32.4	68.8	137.5
Working capital